Please login to the form below

Not currently logged in
Email:
Password:

data access

This page shows the latest data access news and features for those working in and with pharma, biotech and healthcare.

Roche and Illumina partner on genomics for cancer diagnostics

Roche and Illumina partner on genomics for cancer diagnostics

more patients with access to NGS to characterise their disease and identify the right treatment for them,” said Thomas Schinecker, CEO of Roche Diagnostics. ... This builds upon our strategy of accelerating clinical research, streamlining workflows and

Latest news

More from news
Approximately 1 fully matching, plus 192 partially matching documents found.

Latest Intelligence

  • Creativity in storytelling: why pharma must invest more in creativity Creativity in storytelling: why pharma must invest more in creativity

    It sounds like a vote winner. There’s a growing suspicion that pharma’s investment in ‘brand’ is declining, with modern-day powerhouses like data, tech and market access all stealing ... That requires courage, particularly in pharma where

  • Rare diseases: redefining medical communications Rare diseases: redefining medical communications

    Low levels of clinical awareness and expertise, small patient populations, paucity of data, and access to treatment are all factors that drive the need for new approaches, compared with those used ... Access to treatment. The demonstration of value is

  • Real-world studies Real-world studies

    trial recruitment, support regulatory filings, expand patient access and be used for drug safety surveillance. ... This app enables developers to advance new ways to access and use data collected directly from patients, with the necessary controls in

  • Embracing technology and analytics Embracing technology and analytics

    We live in a time where technologies and channels continue to grow and with that we have access to billions of data points to use for analysis. ... Diane Wass, Managing Director and Ken Deutsch, Head of Data and Analytics, JPA Health Communications.

  • Pharmaceutical social media after Cambridge Analytica Pharmaceutical social media after Cambridge Analytica

    But a Facebook loophole also allowed GSR to access the users’ friends’ data. ... EU General Data Protection Regulation (GPDR) has reset the rules on data processing.

More from intelligence
Approximately 0 fully matching, plus 60 partially matching documents found.

Latest appointments

  • Medmeme appoints Dr Joseph Laudano to medical affairs role Medmeme appoints Dr Joseph Laudano to medical affairs role

    He said: “The medical affairs function is in the process of evolving from a traditional support role into a more robust, strategic organisation for data generation and dissemination. ... Mahesh Naithani, founder of Medmeme, said: “Medmeme has been

  • Natasha Giordano joins PLx Pharma Natasha Giordano joins PLx Pharma

    I look forward to building on the compelling clinical data and initial market access work the PLx management team has begun and to successfully launching PL2200 Aspirin into the U.S.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Spotlight interview: 15 minutes on digital in medical communications

    technologies. Often teams do not have access to the relevant expertise to make informed decisions on risk - this impacts projects and can cause errors. ... We expect these will support people to access health data and it will be important for us as an

  • RWE Blog 1: Real-world challenges and real-world data

    This is the first of a set of four blogs on real-world data (RWD) and real-world-evidence (RWE), and their role in market access. ... what the impact of the data will be on market access.

  • Tapping the potential of rare diseases: A journey into uncharted territory

    Low levels of clinical awareness and expertise, small patient populations, paucity of data, and access to treatment are all factors that drive the need for new approaches, compared with those used ... Access to treatment. The demonstration of value is

  • OneTwoZero

    We have access to audiences through our known data so we can pinpoint specific interests and needs of HCPs.

  • Artificial Intelligence in healthcare

    This data represents an opportunity for pharma to bolster their ‘real-word evidence’, a somewhat rare and increasingly sought-after commodity. ... Or providing never-seen-before clinical decision support, with AI scouring a vast breadth of data to

More from PMHub
Approximately 0 fully matching, plus 41 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics